---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-006901"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T01:46:12.322082+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Annual meeting set for June 11, 2024; shareholder proposal deadlines announced

## Summary
- 2024 annual meeting of shareholders scheduled for June 11, 2024.
- Shareholder business or director nominations due by March 15, 2024.
- Shareholder proposals for proxy statement inclusion due by March 29, 2024.
- Notices directed to Corporate Secretary at Carlsbad, CA address.

## SEC filing metadata
- accession: 0001493152-24-006901
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/0001493152-24-006901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-006901
- JSON: https://secwatch.observer/filing/0001493152-24-006901.json
- Plain text: https://secwatch.observer/filing/0001493152-24-006901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.